Summary
The Medical Devices Regulations 2002 implement EU-derived requirements for medical devices in Great Britain, establishing definitions, classifications, conformity assessment procedures, clinical investigation rules, registration requirements, and marking requirements (CE/UKCA). It transposes Directives 90/385, 93/42, and 98/79 into UK law and includes provisions for in vitro diagnostic medical devices, active implantable devices, and various device categories. The regulations establish requirements for manufacturers, approved bodies, UK responsible persons, and设置了监管框架。
Reason
This regulation represents EU-derived legislation retained after Brexit that imposes substantial compliance burdens on medical device manufacturers without clear evidence the costs are justified by benefits. The conformity assessment procedures, notified body requirements, extensive documentation mandates, and technical specifications create significant barriers to entry, particularly for innovative SMEs and new market entrants. While patient safety is a legitimate concern, this prescriptive command-and-control approach is not the only means to achieve it—product liability law, market reputation mechanisms, and voluntary standards could address safety concerns with less regulatory overhead. The regulation's own sunset provisions (regulations 19B, 19C, 30A, 44ZA, 44ZB expiring at various dates) suggest even Parliament recognized certain provisions as temporary fixes rather than permanent optimal policy. Post-Brexit regulatory independence offers the opportunity to streamline device approval while maintaining safety standards, potentially attracting medical device manufacturers who currently face lower barriers in the US, Singapore, or UAE.